DV
Dividend Vision

BIORQ — Biora Therapeutics, Inc.

Biora Therapeutics, Inc. (BIORQ)

Its deepest 1-year drawdown was 98.0%.

This is an equity stock rather than a diversified ETF, representing a single biotech company focused on therapeutic solutions. No distribution rate, expense ratio, or significant asset base is currently available for this holding, indicating it may be a small-cap or newly listed security. It appeals primarily to growth-oriented investors interested in the biotechnology sector rather than income-focused dividend investors.

BIORQ key facts

Asset type
Stock
Asset class
Equity
Inception date
06/19/2020
Last close
$0.0001
Average volume
562.0
Beta
1.37
Payout ratio
0.0
Forward P/E
0.0